Evidence map›Paper›PMID 34384203›Full record

ArticleHealthcare informatics research2021

Machine Learning for Antibiotic Resistance Prediction: A Prototype Using Off-the-Shelf Techniques and Entry-Level Data to Guide Empiric Antimicrobial Therapy.

Georgios Feretzakis, Aikaterini Sakagianni, Evangelos Loupelis, Dimitris Kalles, Nikoletta Skarmoutsou, Maria Martsoukou, Constantinos Christopoulos, Malvina Lada, Stavroula Petropoulou, Aikaterini Velentza and 3 more

Abstract read
In one paragraph

Article in Healthcare informatics research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Artificial intelligence in antimicrobial stewardship: a systematic review and meta-analysis of predictive performance and diagnostic accuracy.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025
    Pooled it
  2. Article
  3. Article
  4. Artificial intelligence in clinical microbiology: results from the first National survey by the Italian association of clinical microbiologists.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Observational
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Georgios FeretzakisSchool of Science and Technology, Hellenic Open University, Patras, Greece.
Aikaterini SakagianniIntensive Care Unit, Sismanogleio General Hospital, Marousi, Greece.
Evangelos LoupelisIT Department, Sismanogleio General Hospital, Marousi, Greece.
Dimitris KallesSchool of Science and Technology, Hellenic Open University, Patras, Greece.
Nikoletta SkarmoutsouClinical Microbiology Laboratory, Sismanogleio General Hospital, Marousi, Greece.
Maria MartsoukouClinical Microbiology Laboratory, Sismanogleio General Hospital, Marousi, Greece.
Constantinos ChristopoulosInternal Medicine Department, Sismanogleio General Hospital, Marousi, Greece.
Malvina LadaInternal Medicine Department, Sismanogleio General Hospital, Marousi, Greece.
Stavroula PetropoulouIT Department, Sismanogleio General Hospital, Marousi, Greece.
Aikaterini VelentzaClinical Microbiology Laboratory, Sismanogleio General Hospital, Marousi, Greece.
Sophia MichelidouIntensive Care Unit, Sismanogleio General Hospital, Marousi, Greece.
Rea ChatzikyriakouHematology Laboratory, Sismanogleio General Hospital, Marousi, Greece.
Evangelos DimitrellosInternal Medicine Department, Sismanogleio General Hospital, Marousi, Greece.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveIn the era of increasing antimicrobial resistance, the need for early identification and prompt treatment of multi-drug-resistant infections is crucial for achieving favorable outcomes in critically ill patients. As traditional microbiological susceptibility testing requires at least 24 hours, automated machine learning (AutoML) techniques could be used as clinical decision support tools to predict antimicrobial resistance and select appropriate empirical antibiotic treatment.

methodsAn antimicrobial susceptibility dataset of 11,496 instances from 499 patients admitted to the internal medicine wards of a public hospital in Greece was processed by using Microsoft Azure AutoML to evaluate antibiotic susceptibility predictions using patients' simple demographic characteristics, as well as previous antibiotic susceptibility testing, without any concomitant clinical data. Furthermore, the balanced dataset was also processed using the same procedure. The datasets contained the attributes of sex, age, sample type, Gram stain, 44 antimicrobial substances, and the antibiotic susceptibility results.

resultsThe stack ensemble technique achieved the best results in the original and balanced dataset with an area under the curve-weighted metric of 0.822 and 0.850, respectively.

conclusionsImplementation of AutoML for antimicrobial susceptibility data can provide clinicians useful information regarding possible antibiotic resistance and aid them in selecting appropriate empirical antibiotic therapy by taking into consideration the local antimicrobial resistance ecosystem.

Indexed as

Anti-Bacterial AgentsArtificial IntelligenceDrug ResistanceMachine LearningSupervised Machine Learning

Identifiers

PMID34384203
PMCPMC8369050

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.